Skip to main content

Advertisement

Log in

Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

This study aimed to analyze the expression, clinical significance of cyclin G2 (CCNG2) in gastric carcinoma, and the biological effect in its cell line by CCNG2 overexpression. Immunohistochemistry and western blot were used to analyze CCNG2 protein expression in 87 cases of gastric cancer and normal tissues to study on the relationship between CCNG2 expression and clinical factors. CCNG2 lentiviral vector was transfected into gastric SGC-7901 cell line. RT-PCR and western blot were used to detect the mRNA level and protein of CCNG2. MTT assay and cell cycle were also conducted as to the influence of the upregulated expression of CCNG2 that might be found on SGC-7901 cell biological effect. Immunohistochemically, the level of CCNG2 protein expression was found to be significantly lower in gastric cancer tissue than in normal tissues (P < 0.05). Western blot shows that the relative amount of CCNG2 protein in gastric cancer tissue was found to be significantly lower than in normal tissues (P < 0.05). The level of CCNG2 protein expression was correlated with T stages, lymph node metastasis, clinical stage, and histological grade (P < 0.05). Loss of CCNG2 expression correlated significantly with poor overall survival time by Kaplan–Meier analysis (P < 0.05). The result of biological function showed that SGC-7901 cell-transfected CCNG2 had a lower survival fraction, higher percentage of the G0/G1 phases, and lower CDK2 protein expression compared with SGC-7901 cell untransfected CCNG2 (P < 0.05). CCNG2 expression decreased in gastric cancer and correlated significantly T stages, lymph node metastasis, clinical stage, histological grade, and poor overall survival, suggesting that CCNG2 may play important roles as a negative regulator to gastric cancer cell by promoting degradation of CDK2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–62.

    PubMed  Google Scholar 

  2. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42:219–40.

    Article  PubMed  Google Scholar 

  3. Ahmed S, Al-Saigh S, Matthews J. FOXA1 is essential for aryl hydrocarbon receptor-dependent regulation of cyclin G2. Mol Cancer Res. 2012;10:636–48.

    Article  PubMed  CAS  Google Scholar 

  4. Bates S, Rowan S, Vousden KH. Characterization of human cyclin G1 and G2: DNA damage inducible genes. Oncogene. 1996;13:1103–9.

    PubMed  CAS  Google Scholar 

  5. Horne MC, Goolsby GL, Donaldson KL, Tran D, Neubauer M, Wahl AF. Cyclin G1 and cyclinG2 comprise a new family of cyclins with contrasting cycle-regulated expression. J Biol Chem. 1996;271:6050–61.

    Article  PubMed  CAS  Google Scholar 

  6. Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT. Cyclin G2 dysregulation in human oral cancer. Cancer Res. 2004; 8980–8986

  7. Cui XF, Liu AJ, Xu ZM. Expression of Cyclin G2 and its clinical significance in laryngeal squamous cell carcinoma. J Clin Torhinolaryngol. 2009;23:277–9.

    Google Scholar 

  8. Shan G, Shan SG, Zhang XB. Expression and clinical significance of cyclin G1 and cyelinG2 in transitional cell carcinoma of bladder. Chin J Histochem Cytochem. 2009;18:268–72.

    CAS  Google Scholar 

  9. Choi MG, Noh JH, An JY, Hong SK, Park SB, Baik YH, et al. Expression levels of cyclinG2, but not cyclin E, correlate with gastric progression. J Surg Res. 2009;157:168–74.

    Article  PubMed  CAS  Google Scholar 

  10. Shi W, Yu KR, Wu GY, Zhang H. Expression of CCNG2 in gastric carcinoma and its relationship with prognosis. Chin J Cell Boil. 2011;33:994–7.

    CAS  Google Scholar 

  11. Song YL, Hu GH. CyclinG2: Correlation with head and neck neoplasms. Int J Otolaryngol-Head Neck Surg. 2006;30:8–11.

    Google Scholar 

  12. Le XF, Arachehige-Don AS, Mao W, Horne MC, Bast RC Jr. Roles of human epidermal growth factor receptor 2, c-Jun NH2- terminal kinase, phosphoinositide

  13. Martinez-GacL, Marqués M, García Z, Campanero MR, Carrera AC. Control of cyclinG2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol. 2004;4:2181–9.

    Article  CAS  Google Scholar 

  14. Chen J, Yusuf L, Andersen HM, Fruman DA. FOXO transcription factors cooperate with δEF1 to activate growth suppressive genes in B-lymphocytes. J Immunol. 2006;76:2711–21.

    Article  Google Scholar 

  15. Xu G, Bernaudo S, Fu G, Lee DY, Yang BB, Peng C. CyclinG2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7. Mol Biol Cell. 2008;9:4968–79.

    Article  CAS  Google Scholar 

  16. Cellai C, Laurenzana A, Bianchi E, Sdelci S, Manfredini R, Vannucchi AM, et al. Mechanistic insight intoWEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN. Exp Hematol. 2009;7:1176–85.

    Article  CAS  Google Scholar 

  17. van Duijn PW, van der Ziel Made AC, van der Korput JA, Trapman J. PTEN-mediated Gl cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators. Prostate. 2010;70:135–46.

    PubMed  Google Scholar 

  18. Horne MC, Donaldson KL, Goolsby GL, Tran D, Mulheisen M, Hell JW, et al. Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem. 1997;272:12650–61.

    Article  PubMed  CAS  Google Scholar 

  19. Bennin DA, Don AS, Brake T, McKenzie JL, Rosenbaum H, Ortiz L, et al. Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a Gl/S phase cell cycle arrest. J Biol Chem. 2002;2779:27449–67.

    Article  CAS  Google Scholar 

  20. Arachchige Don AS, Dallapiazza RF, Bennin DA, Brake T, Cowan CE, Horne MC. CyclinG2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a P53- dependent cell cycle arrest. Exp Cell Res. 2006;312:4181–204.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. G. Sun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, G.G., Hu, W.N., Cui, D.W. et al. Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma. Tumor Biol. 35, 2631–2639 (2014). https://doi.org/10.1007/s13277-013-1346-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1346-2

Keywords

Navigation